SQI Diagnostics Inc. announced the appointment of global healthcare executive Eric Zwisler, to its Board of Directors. Eric Zwisler has been a senior executive in the healthcare business for over 30 years. Most recently he was Chairman of Cardinal Health China. In addition to his role at Cardinal Health, for the last several years Eric has also been active in healthcare investments, other board roles and education. He spent many of the last 30 years in Asia, particularly China where he won major awards from the Chinese government for his business acumen and commitment to the development of the healthcare industry in the world's fastest-growing market. Last year, he played a key role in the sale of Cardinal Health China to a local company for $1.2 billion and participated in the deal process by leading a management buy-out proposal. Mr. Zwisler is an internationalist who has worked extensively with businesses and investors from the United States, Europe, Japan and South America. He is a proven leader of large organizations and is operationally adept in strategic, operational, commercial and financial matters. He also has extensive board experience in healthcare services, immunology research and development, and is well-versed in capital structure issues and strategy, financial controls and management, as well as compliance matters.